Page last updated: 2024-10-24

celecoxib and Gangrene

celecoxib has been researched along with Gangrene in 1 studies

Gangrene: Death and putrefaction of tissue usually due to a loss of blood supply.

Research Excerpts

ExcerptRelevanceReference
"Celecoxib dosage was fixed."2.75A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer. ( Alqaisi, M; Bernal, P; Bush, D; Byrd, J; Garberoglio, C; Hussein, F; Malik, I, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malik, I1
Hussein, F1
Bush, D1
Alqaisi, M1
Bernal, P1
Byrd, J1
Garberoglio, C1

Trials

1 trial available for celecoxib and Gangrene

ArticleYear
A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.
    American journal of clinical oncology, 2010, Volume: 33, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitab

2010